A cross-sectional study published in AIDS Research and Therapy reports that dysregulation of the transforming growth factor-β (TGF-β)/Smad signaling pathway and specific changes in microRNA expression within peripheral blood mononuclear cells are associated with markers of systemic inflammation in people living with HIV. The research, led by Shanmei Zhong and colleagues, examined the relationship between these immunoregulatory mechanisms and inflammatory markers in a cohort of 70 participants, comprising 33 individuals living with HIV and 37 HIV-negative controls. The findings suggest that persistent inflammation in people living with HIV, even when viral load is suppressed by antiretroviral therapy, may be coordinated by complex interactions between TGF-β signaling components and microRNA expression profiles.
The study was motivated by the clinical observation that people living with HIV continue to experience non-AIDS comorbidities despite effective antiretroviral treatment. The TGF-β/Smad pathway is a central axis in immune regulation, yet its specific coordination with peripheral blood mononuclear cell-derived microRNA expression and its mechanistic links to monocyte activation and hepatic inflammation had not been previously characterized. The researchers aimed to explore these associations in an exploratory cross-sectional design, measuring serum levels of TGF-β1, soluble CD14 (sCD14), C-reactive protein (CRP), and interferon-γ-inducible protein 10 (IP-10/CXCL10) using enzyme-linked immunosorbent assay. Additionally, the team quantified the mRNA levels of Smad2, Smad3, Smad4, Smad7, and TGFβ-R1/R2, as well as eight specific PBMC-derived microRNAs, through quantitative reverse transcription PCR.
Statistical analysis involved age- and sex-adjusted multivariable linear regression and partial Spearman rank correlation analyses, stratified by HIV status. For the subgroup of participants living with HIV, the researchers also performed multivariable sensitivity models that adjusted for age, sex, CD4+ T-cell count, and duration of antiretroviral therapy.
The results revealed significant differences in inflammatory markers between the two groups. Participants living with HIV exhibited significantly elevated levels of sCD14, a marker of monocyte activation, with a median of 10.56 log2 ng/mL compared to 9.61 log2 ng/mL in controls. Conversely, serum TGF-β1 levels were significantly downregulated in the HIV-positive group, with a median of 3.44 log2 ng/mL versus 4.61 log2 ng/mL in controls. The study also found that Smad4 mRNA expression was lower in people living with HIV. These opposing trends in TGF-β1 and sCD14 suggest a potential imbalance in the regulatory pathways governing monocyte activation and systemic inflammation in the context of chronic HIV infection.
At the molecular level, three PBMC-derived microRNAs were found to be significantly upregulated in the HIV-positive group: miR-7-5p, miR-9-5p, and miR-519d-3p. Stratified correlation analysis indicated that the structural relationship between these microRNAs and the TGF-β/Smad pathway was reorganized in people living with HIV compared to controls. Specifically, the network of correlations in the HIV-positive group was predominantly anchored by Smad2, whereas the control group’s network was anchored by Smad3. This shift in correlation structure implies that the regulatory logic connecting microRNA expression to TGF-β signaling components differs fundamentally between healthy individuals and those living with HIV.
Regression analyses further clarified the specific links between these molecular markers and inflammatory proteins. In the full analytical sample, miR-519d-3p was inversely associated with TGF-β1 levels. Additionally, lower levels of Smad3 and TGFβ-R2 mRNA were linked to elevated CRP levels, a key marker of systemic inflammation. Four specific microRNAs—miR-519d-3p, miR-7-5p, miR-103a-3p, and miR-9-5p—were positively associated with sCD14 levels across the entire sample. In the HIV-only sensitivity models, the association between TGFβ-R2 and CRP remained significant, while the associations between sCD14 and the microRNAs were attenuated, suggesting that these specific links may be more robust in the broader population or may depend on factors not fully captured in the HIV-specific model.
The authors conclude that coordinated dysregulation of PBMC-derived microRNAs is associated with two distinct inflammatory patterns in the study sample. The first pattern involves the attenuation of TGF-β/Smad signaling linked to elevated CRP, with specific support for the TGFβ-R2–CRP association in the HIV-positive subgroup. The second pattern involves microRNA associations with monocyte activation, as measured by sCD14, which require further validation. The study emphasizes that these findings are hypothesis-generating and warrant confirmation in larger longitudinal cohorts that include comprehensive clinical metadata and cell-type-resolved functional assays to better understand the causal mechanisms at play.
Despite the limitations of a cross-sectional design, which precludes causal inference, the study provides valuable insights into the molecular landscape of persistent inflammation in people living with HIV. By linking specific microRNA changes to alterations in the TGF-β/Smad pathway and inflammatory markers, the research offers a potential framework for understanding how chronic immune activation may drive non-AIDS comorbidities.
Subject of Research: Association between TGF-β/Smad signaling, PBMC-derived miRNA expression, and systemic inflammation in people living with HIV.
Article Title: TGF-β/Smad signaling pathway dysregulation and differential PBMC-derived miRNA expression are associated with systemic inflammation in people living with HIV: a cross-sectional study
Article References: Zhong, S., Zhang, Y., Luo, X., Liu, X., Huang, L., Deng, S., Sun, X., Wu, H., Qin, J., He, S., Liang, H., & Su, Q. (2026). TGF-β/Smad signaling pathway dysregulation and differential PBMC-derived miRNA expression are associated with systemic inflammation in people living with HIV: a cross-sectional study. AIDS Research and Therapy. https://doi.org/10.1186/s12981-026-00933-x
Image Credits: AI Generated
DOI: 10.1186/s12981-026-00933-x
Keywords: HIV, Systemic Inflammation, TGF-β/Smad Signaling, MicroRNA, Cross-Sectional Study, Monocyte Activation, Antiretroviral Therapy, Immunology, TGF-, Smad, signaling, pathway
News Source: Ophelia Keating. (November 10, 2026). HIV Inflammation Linked to TGF-β and miRNA Changes. Scienmag.



